2 búsqueda de la palabra clave 'graft rejection'

Treatment of post-biopsy arteriovenous fistula of a renal graft by selective embolization / José Miguel Hidalgo Oviedo ; Sergio Álvarez Vallejo ; Arbey Aristizabal Álzate ; Gustavo Adolfo Zuluaga Valencia ; John Fredy Nieto Ríos  

Público ISBD Título : Treatment of post-biopsy arteriovenous fistula of a renal graft by selective embolization Tipo de documento : documento electrónico Autores : José Miguel Hidalgo Oviedo, ; Sergio Álvarez Vallejo, ; Arbey Aristizabal Álzate, ; Gustavo Adolfo Zuluaga Valencia, ; John Fredy Nieto Ríos, Fecha de publicación : 2021 Títulos uniformes : Indian Journal of Nephrology Idioma : Inglés (eng) Palabras clave : Arteriovenous fistula  kidney transplantation  graft biopsy  graft rejection  selective embolization Resumen : The development of an arteriovenous fistula (AVF) after renal graft biopsy is a rare complication, it is associated in most cases with spontaneous resolution. However, interventional therapies are required in some cases, to prevent graft loss. Selective embolization has been described as an alternative treatment. In the present study, we describes our experience on AVF after biopsy in kidney transplant patients, which was managed with selective embolization. From 2005 to 2015, a total of 452 kidney transplant biopsies were performed, 12 had an AVF requiring embolization. In 92% of cases, this was successful. Beforehand, mean serum creatinine levels were 2.45 mg/dL, after the procedure, that increased to 3.05, however, 3 months later, mean creatinine levels dropped to 1.85 mg/dL. Graft survival after 2 follow-up years was 72%. Our experience demonstrates that selective embolization of the AVF after kidney transplant biopsy is a safe procedure, and that transplant function can be maintained in patients with this complication. Mención de responsabilidad : Lina M Serna-Higuita, Monica Zuluaga-Quintero, Jose M Hidalgo-Oviedo, Sergio Alvarez Vallejo, Arbey Aristizabal-Alzate, Gustavo A Zuluaga-Valencia, John F Nieto-Ríos Referencia : Indian J Nephrol. Mar-Apr 2021;31(2):201-204. DOI (Digital Object Identifier) : 10.4103/ijn.IJN_351_19 PMID : 34267449 En línea : https://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2021;volume=31;is [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5777 Treatment of post-biopsy arteriovenous fistula of a renal graft by selective embolization [documento electrónico] / José Miguel Hidalgo Oviedo, ; Sergio Álvarez Vallejo, ; Arbey Aristizabal Álzate, ; Gustavo Adolfo Zuluaga Valencia, ; John Fredy Nieto Ríos,  . - 2021. Obra : Indian Journal of Nephrology Idioma : Inglés (eng) Palabras clave : Arteriovenous fistula  kidney transplantation  graft biopsy  graft rejection  selective embolization Resumen : The development of an arteriovenous fistula (AVF) after renal graft biopsy is a rare complication, it is associated in most cases with spontaneous resolution. However, interventional therapies are required in some cases, to prevent graft loss. Selective embolization has been described as an alternative treatment. In the present study, we describes our experience on AVF after biopsy in kidney transplant patients, which was managed with selective embolization. From 2005 to 2015, a total of 452 kidney transplant biopsies were performed, 12 had an AVF requiring embolization. In 92% of cases, this was successful. Beforehand, mean serum creatinine levels were 2.45 mg/dL, after the procedure, that increased to 3.05, however, 3 months later, mean creatinine levels dropped to 1.85 mg/dL. Graft survival after 2 follow-up years was 72%. Our experience demonstrates that selective embolization of the AVF after kidney transplant biopsy is a safe procedure, and that transplant function can be maintained in patients with this complication. Mención de responsabilidad : Lina M Serna-Higuita, Monica Zuluaga-Quintero, Jose M Hidalgo-Oviedo, Sergio Alvarez Vallejo, Arbey Aristizabal-Alzate, Gustavo A Zuluaga-Valencia, John F Nieto-Ríos Referencia : Indian J Nephrol. Mar-Apr 2021;31(2):201-204. DOI (Digital Object Identifier) : 10.4103/ijn.IJN_351_19 PMID : 34267449 En línea : https://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2021;volume=31;is [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5777

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD001704	AC-2021-027	Archivo digital	Producción Científica	Artículos científicos	Disponible

Tuberculosis in renal transplant patients: the experience of a single center in Medellín-Colombia, 2005-2013 / Lina Maria Serna Higuita ; John Fredy Nieto Ríos ; Catalina Ocampo Kohn ; Arbey Aristizabal Álzate ; Catalina Vélez Echeverri ; Juan José Vanegas Ruiz ; Isabel Cristina Ramírez Sánchez ; John Jairo Zuleta Tobón ; Gustavo Adolfo Zuluaga Valencia    

Público ISBD Título : Tuberculosis in renal transplant patients: the experience of a single center in Medellín-Colombia, 2005-2013 Tipo de documento : documento electrónico Autores : Lina Maria Serna Higuita, ; John Fredy Nieto Ríos, ; Catalina Ocampo Kohn, ; Arbey Aristizabal Álzate, ; Catalina Vélez Echeverri, ; Juan José Vanegas Ruiz, ; Isabel Cristina Ramírez Sánchez, ; John Jairo Zuleta Tobón, ; Gustavo Adolfo Zuluaga Valencia, Fecha de publicación : 2014 Títulos uniformes : Brazilian Journal of Nephrology Idioma : Inglés (eng) Palabras clave : Graft rejection  kidney transplantation  mycobacterium tuberculosis Resumen : Introduction: Tuberculosis is a common opportunistic infection in renal transplant patients. Objective: To obtain a clinical and laboratory description of transplant patients diagnosed with tuberculosis and their response to treatment during a period ranging from 2005 to 2013 at the Pablo Tobón Uribe Hospital. Methods: Retrospective and descriptive study. Results: In 641 renal transplants, tuberculosis was confirmed in 12 cases. Of these, 25% had a history of acute rejection, and 50% had creatinine levels greater than 1.5 mg/dl prior to infection. The disease typically presented as pulmonary (50%) and disseminated (33.3%). The first phase of treatment consisted of 3 months of HZRE (isoniazid, pyrazinamide, rifampicin and ethambutol) in 75% of the cases and HZME (isoniazid, pyrazinamide, moxifloxacin and ethambutol) in 25% of the cases. During the second phase of the treatment, 75% of the cases received isoniazid and rifampicin, and 25% of the cases received isoniazid and ethambutol. The length of treatment varied between 6 and 18 months. In 41.7% of patients, hepatotoxicity was associated with the beginning of anti-tuberculosis therapy. During a year-long follow-up, renal function remained stable, and the mortality rate was 16.7%. Conclusion: Tuberculosis in the renal transplant population studied caused diverse nonspecific symptoms. Pulmonary and disseminated tuberculosis were the most frequent forms and required prolonged treatment. Antituberculosis medications had a high toxicity and mortality. This infection must be considered when patients present with a febrile syndrome of unknown origin, especially during the first year after renal transplant. Mención de responsabilidad : Lina Maria Serna Higuita, John Fredy Nieto-Ríos, Salomon Daguer-Gonzalez, Catalina Ocampo-Kohn, Arbey Aristizabal-Alzate, Catalina Velez-Echeverri, Juan Jose Vanegas-Ruiz, Isabel Ramirez-Sanchez, Jhon Jairo Zuleta Tobon, Gustavo Adolfo Zuluaga-Valencia Referencia : J Bras Nefrol. 2014 Oct-Dec;36(4):512-8. DOI (Digital Object Identifier) : 10.5935/0101-2800.20140073 PMID : 25517281 Derechos de uso : CC BY-NC En línea : http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002014000400512&l [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4546 Tuberculosis in renal transplant patients: the experience of a single center in Medellín-Colombia, 2005-2013 [documento electrónico] / Lina Maria Serna Higuita, ; John Fredy Nieto Ríos, ; Catalina Ocampo Kohn, ; Arbey Aristizabal Álzate, ; Catalina Vélez Echeverri, ; Juan José Vanegas Ruiz, ; Isabel Cristina Ramírez Sánchez, ; John Jairo Zuleta Tobón, ; Gustavo Adolfo Zuluaga Valencia,  . - 2014. Obra : Brazilian Journal of Nephrology Idioma : Inglés (eng) Palabras clave : Graft rejection  kidney transplantation  mycobacterium tuberculosis Resumen : Introduction: Tuberculosis is a common opportunistic infection in renal transplant patients. Objective: To obtain a clinical and laboratory description of transplant patients diagnosed with tuberculosis and their response to treatment during a period ranging from 2005 to 2013 at the Pablo Tobón Uribe Hospital. Methods: Retrospective and descriptive study. Results: In 641 renal transplants, tuberculosis was confirmed in 12 cases. Of these, 25% had a history of acute rejection, and 50% had creatinine levels greater than 1.5 mg/dl prior to infection. The disease typically presented as pulmonary (50%) and disseminated (33.3%). The first phase of treatment consisted of 3 months of HZRE (isoniazid, pyrazinamide, rifampicin and ethambutol) in 75% of the cases and HZME (isoniazid, pyrazinamide, moxifloxacin and ethambutol) in 25% of the cases. During the second phase of the treatment, 75% of the cases received isoniazid and rifampicin, and 25% of the cases received isoniazid and ethambutol. The length of treatment varied between 6 and 18 months. In 41.7% of patients, hepatotoxicity was associated with the beginning of anti-tuberculosis therapy. During a year-long follow-up, renal function remained stable, and the mortality rate was 16.7%. Conclusion: Tuberculosis in the renal transplant population studied caused diverse nonspecific symptoms. Pulmonary and disseminated tuberculosis were the most frequent forms and required prolonged treatment. Antituberculosis medications had a high toxicity and mortality. This infection must be considered when patients present with a febrile syndrome of unknown origin, especially during the first year after renal transplant. Mención de responsabilidad : Lina Maria Serna Higuita, John Fredy Nieto-Ríos, Salomon Daguer-Gonzalez, Catalina Ocampo-Kohn, Arbey Aristizabal-Alzate, Catalina Velez-Echeverri, Juan Jose Vanegas-Ruiz, Isabel Ramirez-Sanchez, Jhon Jairo Zuleta Tobon, Gustavo Adolfo Zuluaga-Valencia Referencia : J Bras Nefrol. 2014 Oct-Dec;36(4):512-8. DOI (Digital Object Identifier) : 10.5935/0101-2800.20140073 PMID : 25517281 Derechos de uso : CC BY-NC En línea : http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002014000400512&l [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4546

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD001043	AC-2014-114	Archivo digital	Producción Científica	Artículos científicos	Disponible

Documentos electrónicos

2014-114.pdf Adobe Acrobat PDF